ANNX News and Press, Annexon Inc.

New Fortress Energy Inc. (NFE) is expected to report $-1.08 for Q4 2025 Design Therapeutics Inc. (DSGN) is expected to report $-0.38 for Q4 2025 Beta Technologies Inc. Class A (BETA) is expected to report $-0.52 for Q4 2025 Yext Inc. (YEXT) is expected to report $0.06 for Q4 2026 ...

Astrana Health Inc. (ASTH) is expected to report $0.15 for Q4 2025 Sealed Air Corporation (SEE) is expected to report $0.72 for Q4 2025 Surgery Partners Inc. (SGRY) is expected to report $0.27 for Q4 2025 Kuehne + Nagel International AG ADR (KHNGY) is expected to report $0.4 for Q4 20...

BRISBANE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, E...

BRISBANE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it will host an...

2026-01-27 12:41:35 ET The market has definitely started to care more about Belite Bio ( BLTE ) in the last few months, as the shares of this ophthalmology-focused biotech have risen roughly 150% since late September. The stock has likewise started attracting the attention of larger sel...

2026-01-24 02:08:31 ET Although systemic complement-mediated diseases are, fortunately, relatively rare, there is a wider range of diseases where complement overactivation plays a significant role, and these are often hard-to-treat diseases with serious quality of life implications. Ann...

BRISBANE, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted ...

2026-01-14 17:15:45 ET More news and analysis Sidus Space: Launching Into High-Margin Satellite Data Services Market Annexon, Inc. (ANNX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Pacira BioSciences, Inc. (PCRX) Presents at 44th Annual J.P....

2026-01-14 17:06:03 ET Annexon, Inc. (ANNX) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 2:15 PM EST... Read the full article on Seeking Alpha For further details see: Annexon, Inc. (ANNX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Tanruprubart MAA Filed with Potential to Be the First Targeted Fast-Acting Therapy for  Guillain-Barré Syndrome ( GBS); BLA Submission with U.S./European Data Planned in 2026 Vonaprument Pivotal Phase 3 Topline Data for Dry AMD with Geographic Atrophy (GA) on Track for Second Half...